|Articles|September 1, 2017
A Managed Care Perspective: Treatment of Idiopathic Pulmonary Fibrosis
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment
2
Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations
3
New Dermatologic Therapies Make Waves at Maui Derm 2026
4
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
5
